Marine Compounds and Cancer

Marine Compounds and Cancer PDF Author: Friedemann Honecker
Publisher: MDPI
ISBN: 3038421316
Category :
Languages : en
Pages : 120

Get Book

Book Description
This book is a printed edition of the Special Issue "Marine Compounds and Cancer" that was published in Marine Drugs

Marine Compounds and Cancer

Marine Compounds and Cancer PDF Author: Friedemann Honecker
Publisher: MDPI
ISBN: 3038421316
Category :
Languages : en
Pages : 120

Get Book

Book Description
This book is a printed edition of the Special Issue "Marine Compounds and Cancer" that was published in Marine Drugs

Marine Compounds and Cancer

Marine Compounds and Cancer PDF Author: Friedemann Honecker
Publisher: MDPI
ISBN: 3038427659
Category : Electronic books
Languages : en
Pages : 119

Get Book

Book Description
This book is a printed edition of the Special Issue "Marine Compounds and Cancer" that was published in Marine Drugs

Marine Compounds and Cancer

Marine Compounds and Cancer PDF Author: Friedemann Honecker
Publisher: Mdpi AG
ISBN: 9783036506302
Category : Science
Languages : en
Pages : 480

Get Book

Book Description
The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.

Marine Compounds and Cancer

Marine Compounds and Cancer PDF Author:
Publisher: Mdpi AG
ISBN: 9783038421320
Category : Health & Fitness
Languages : en
Pages : 756

Get Book

Book Description
This book is based on a Special Issue called "Marine Compounds and Cancer" (http: //www.mdpi.com/journal/marinedrugs/special_issues/marine-compounds-cancer) of the open access journal, Marine Drugs (ISSN 1660-3397), which was running for two years (2013-2015). It comprises 39 articles in total, a quarter of which are reviews, summarizing the current state of the art in different topics of marineanti-cancer agents. It covers the full scope from agents with cancer-preventive activity, to novel and previously characterized compounds with anti-canceractivity, both in vitro and in vivo, and the latest status of clinical development of marine agents used in clinical trials.

Marine Compounds and Cancer 2017

Marine Compounds and Cancer 2017 PDF Author: Friedemann Honecker
Publisher:
ISBN: 9783038427667
Category :
Languages : en
Pages :

Get Book

Book Description
Marine Compounds and Cancer 2017.

Handbook of Anticancer Drugs from Marine Origin

Handbook of Anticancer Drugs from Marine Origin PDF Author: Se-Kwon Kim
Publisher: Springer
ISBN: 3319071459
Category : Science
Languages : en
Pages : 801

Get Book

Book Description
This timely desk reference focuses on marine-derived bioactive substances which have biological, medical and industrial applications. The medicinal value of these marine natural products are assessed and discussed. Their function as a new and important resource in novel, anticancer drug discovery research is also presented in international contributions from several research groups. For example, the potential role of Spongistatin, Apratoxin A, Eribulin mesylate, phlorotannins, fucoidan, as anticancer agents is explained. The mechanism of action of bioactive compounds present in marine algae, bacteria, fungus, sponges, seaweeds and other marine animals and plants are illustrated via several mechanisms. In addition, this handbook lists various compounds that are active candidates in chemoprevention and their target actions. The handbook also places into context the demand for anticancer nutraceuticals and their use as potential anti-cancer pharmaceuticals and medicines. This study of advanced and future types of natural compounds from marine sources is written to facilitate the understanding of Biotechnology and its application to marine natural product drug discovery research.

Official Gazette of the United States Patent and Trademark Office

Official Gazette of the United States Patent and Trademark Office PDF Author:
Publisher:
ISBN:
Category : Trademarks
Languages : en
Pages : 380

Get Book

Book Description


Marine Natural Products as Anticancer Agents 2.0

Marine Natural Products as Anticancer Agents 2.0 PDF Author: Celso Alves
Publisher: Mdpi AG
ISBN: 9783036575681
Category :
Languages : en
Pages : 0

Get Book

Book Description
Global cancer incidence and death are expected to increase in the next decades. Inappropriate therapeutic regimens and tumor recurrence due to the development of drug resistance are two major clinical challenges impacting poor patient outcomes, which is critical to the discovery and development of new anticancer drugs. Over the last few decades, the marine environment has proved to be a key source of molecules with potent anticancer properties. The Special Issue, "Marine Natural Products as Anticancer Agents 2.0", gathered eleven publications, including two reviews and nine research articles, about the anticancer activities of marine natural and/or derived products on in vitro 2D and 3D cellular models, and/or in vivo models of colorectal, breast, lung, myeloma, liver, leukemia, and melanoma cancers. Altogether, the eleven scientific papers published in this Special Issue provide an exciting overview of marine natural products as potential anticancer agents.

Marine Pharmacognosy

Marine Pharmacognosy PDF Author: Se-Kwon Kim
Publisher: CRC Press
ISBN: 1439892296
Category : Medical
Languages : en
Pages : 457

Get Book

Book Description
Diverse and abundant, marine-derived bioactive compounds offer a plethora of pharmacologically active agents with the potential to produce valuable therapeutic entities. Marine-derived organisms, including some macroalgae, microalgae, blue-green algae, invertebrates, and vertebrates—valued in traditional Chinese medicine since ancient times—are now recognized as rich sources of pharmaceutically active compounds. These factors, coupled with the growing need for novel bioactives for the treatment of severe human diseases such as cancer, diabetes, microbial infections, and inflammatory processes, has brought marine pharmaceuticals to the forefront of pharmacology. Marine Pharmacognosy: Trends and Applications provides a comprehensive account of marine-derived bioactive pharmaceuticals and their potential health benefits, including antioxidant, anticancer, antiviral, anticoagulant, antidiabetic, antiallergy, anti-inflammatory, antihypertensive, antibacterial, and radioprotective activities. Moreover, it discusses the sources, isolation and purification, chemistry, functionality interactions, applications, and industrial features of a variety of marine-derived pharmaceuticals. Marine pharmacognosy is a dynamic field that has been systematically investigated over the last 50 years, and the number of publications and patents are increasing every year. Bringing together a global team of experts, Marine Pharmacognosy: Trends and Applications reviews current research on marine-derived bioactive compounds and provides insight into future research on their potential as pharmacologically active agents.

Autologous Stem Cell Transplantation

Autologous Stem Cell Transplantation PDF Author: Angelo Carella
Publisher: Routledge
ISBN: 1000141322
Category : Medical
Languages : en
Pages : 472

Get Book

Book Description
This textbook integrates basic research and clinical aspects underlying the most recent results in those malignant diseases where progress is most effective. Recent evidence shows that higher doses are better in inducing higher cure rates in hematological neoplasias, although myeloblation related to dose intensity can be a limiting factor. The toxicity can now be controlled with autologous marrow and peripheral blood progenitor cell transplantation, used with or without growth factors. The combination of high dose chemoradiotherapy followed by re-infusion of autologous stem cells constitute a dramatic advance in the treatment of refactory and relapse hematological neoplasias.